Clinical Study Links ThymoQuin to Improved Stress Resilience and Sleep Outcomes

A new human clinical study has been published evaluating the effects of TriNutra’s patented ingredient, ThymoQuin, on stress resilience in adults experiencing moderate stress.¹

The findings, published in EC Nutrition,² highlight statistically significant improvements across multiple physiological and subjective markers associated with the body’s stress response.

This marks the second clinical study demonstrating its benefits in this area, building on prior research conducted in endurance runners that was published in 2022, which had shown that ThymoQuin significantly reduced upper respiratory tract complaints (URTCs) and enhanced overall psychological well-being following intense endurance training and competition.³

The latest study—running for 8 weeks as opposed to 4—was designed as a randomized, placebo-controlled trial involving a heterogeneous group of moderately stressed adults. Researchers assessed key biomarkers, including cortisol and dehydroepiandrosterone (DHEA), alongside measures of sleep quality, mood, and vitality.

According to the results, participants supplementing with ThymoQuin experienced a 23% reduction in cortisol levels, a 10% increase in DHEA, and a 29% improvement in the DHEA-to-cortisol ratio, an indicator often associated with stress resilience. Subjective outcomes also included a 31% improvement in sleep quality and enhanced feelings of vigor.

Why are Cortisol and DHEA Important in Stress Management?

Cortisol and DHEA are central components of the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the body’s response to stress. While cortisol plays a critical role in acute stress adaptation, chronically elevated levels have been linked to negative health outcomes, including disrupted sleep, mood imbalances, and metabolic dysfunction.

DHEA, by contrast, is often described as a counter-regulatory hormone, helping to buffer some of cortisol’s effects. The ratio between DHEA and cortisol is therefore considered a useful marker of how well the body is adapting to ongoing stress.

In the current study, improvements in both cortisol reduction and DHEA elevation suggest a rebalancing of the HPA axis. Researchers noted that these changes were aligned with improvements in sleep and perceived vitality, pointing to a broader systemic response rather than an isolated biomarker shift.

How Does ThymoQuin Support Multi-System Stress Adaptation?

ThymoQuin is a standardized black seed oil extract designed to deliver a consistent level of thymoquinone, a bioactive compound associated with antioxidant and anti-inflammatory activity. The study findings suggest that the ingredient may exert effects across multiple physiological systems involved in stress regulation.

The observed benefits were not limited to biochemical markers, as improvements in sleep quality and subjective energy levels indicated that ThymoQuin may support the body’s natural recovery processes. According to the study authors, this pattern suggests a mechanism aligned more closely with adaptogenic activity, helping the body adapt to stress, rather than acting as a stimulant or sedative.

Morris Zelkha, TriNutra’s CEO, also commented on the findings, noting that, “stress is a system-wide challenge. What makes this study compelling is that ThymoQuin demonstrated a coordinated effect across cortisol balance, adrenal function, sleep, and perceived energy.”

What is the Stress Resilience Index Introduced in the Study?

A notable aspect of the research is the introduction of the Stress Resilience Index (SRI), a composite measure designed to evaluate stress adaptation across multiple domains, including endocrine function, psychological state, and sleep quality.

This approach reflects a broader shift in clinical research toward assessing whole-body resilience rather than focusing on single biomarkers. By integrating multiple endpoints, the SRI aims to provide a more comprehensive understanding of how interventions impact the body’s ability to cope with stress.

The alignment of endocrine improvements with subjective outcomes in this study supports the relevance of such composite measures, particularly in the context of stress-related health conditions, which are inherently multi-factorial.

What Does This Mean for the Stress and Mood Support Category?

The publication of this study comes during a time of growing consumer demand for solutions targeting stress, sleep, and overall mental well-being. As explained in this year’s “Ingredients to Watch,” the category is increasingly shifting toward multi-functional, clinically substantiated ingredients that address interconnected physiological systems rather than single endpoints.

In this context, ingredients like ThymoQuin may offer formulators opportunities to develop products positioned around stress resilience, a concept that resonates with consumers seeking proactive, daily wellness solutions.

Zelkha noted that the findings contribute to a growing body of evidence supporting ThymoQuin as a system-level ingredient, being that, “as consumers increasingly look for solutions to manage and balance everyday stress, the industry needs ingredients backed by meaningful, system-level science.”

References

1. New clinical study demonstrates ThymoQuin enhances stress resilience through cortisol balance, sleep, and vitality. TriNutra. Published March 30, 2026. Accessed April 1, 2026. Press release received via email.

2. Talbott SM, Talbott JA. Supplementation with proprietary and patented black seed oil improves stress resilience in moderately stressed adults: An 8-week randomized, placebo-controlled study.” EC Nutrition 21.3 (2026): 01–09.

3. Talbott SM, Talbott JA, et al. Effect of ThymoQuin black cumin seed oil as a natural immune modulator of upper-respiratory tract complaints and psychological mood state. Food Sci Nutr Res. 2022; 5(1): 1-6.